BioSpace News Archive

Deals

Vertex Buys Alpine for $4.9B to Bolster Autoimmune and Inflammatory Disease Pipeline

Vertex Pharmaceuticals on Wednesday announced it is acquiring clinical-stage immunotherapy company Alpine Immune Sciences for $4.9 billion in cash, the largest acquisition so far this year.

April 11, 2024
·
2 min read
·
Tristan Manalac
Business

Novartis Inks $1B Protein Degrader Deal with Arvinas, Begins MorphoSys Tender Offer

Novartis on Thursday announced that it is making $150 million in upfront payments to protein degradation biotech Arvinas, while separately revealing that its tender offer for MorphoSys has begun.

April 11, 2024
·
3 min read
·
Tristan Manalac
Policy

DOJ Sues Regeneron for Allegedly Inflating Medicare Pricing for Eye Drug Eylea

The U.S. Department of Justice has filed a complaint against Regeneron alleging that the pharma knowingly omitted credit card price concessions for Eylea to inflate Medicare reimbursement rates.

April 11, 2024
·
2 min read
·
Tristan Manalac
Drug Development

4 Investigational Weight Loss Drugs That Could Change the Market

GLP-1 treatments are all the rage in this space, but they aren’t the only approach in development. The pipeline assets highlighted here offer a differentiated approach, potentially increasing efficacy or reducing side effects.

April 11, 2024
·
4 min read
·
Ben Hargreaves
Business

Moderna Halts Plans for Kenyan mRNA Vaccine Plant After Taking $1B Financial Hit

Moderna Thursday said it paused plans to build an mRNA manufacturing facility in Kenya to buy time to assess vaccine demand after being hit with $1 billion in losses and write-downs due to canceled orders.

April 11, 2024
·
2 min read
·
Nick Paul Taylor
Drug Development

Amylyx Plots New Path in Rare Genetic Disease After Relyvrio Withdrawal

On the heels of withdrawing Relyvrio from the U.S. and Canadian markets, Amylyx is now charting a path in Wolfram syndrome with promising interim Phase II data for its lead asset AMX0035.

April 11, 2024
·
2 min read
·
Tristan Manalac
Drug Development

Vaccines, Next-Gen Approaches Target the Toughest Cancers: AACR

Data presented at the American Association for Cancer Research’s annual meeting sparked hope that we could be getting closer to treating pancreatic cancer, glioblastoma and other particularly difficult tumors.

April 11, 2024
·
3 min read
·
Heather McKenzie
Drug Development

US Drug Shortages Reach All-Time High Since 2001: Report

The American Society of Health-System Pharmacists has released statistics showing the number of active and ongoing U.S. drug shortages has reached 323, the highest number since it began tracking the data.

April 11, 2024
·
2 min read
·
Kate Goodwin
Job Trends

2024 Q1 Job Market Report: Competition for Jobs Remains High

The job response rate has risen year over year, according to BioSpace data, indicating competition for roles posted on our website has increased.

April 11, 2024
·
1 min read
·
Chantal Dresner
Genetown

Metrion Biosciences Enhances High Throughput Screening Services With Access to Enamine Compound Libraries

Metrion Biosciences Limited and Enamine Ltd announced that Metrion has enhanced its High Throughput Screening services with the addition of access to Enamine’s compound libraries.

April 11, 2024
·
2 min read